List of Vendor Companies in Alabama - 19

Specialize in molecular and toxicology assays and technology.COVID-19: Molecular test, EUA (05/2020)

As a primary turkey breeder, we are aware of our responsibility to both our customers and the environment. Investment and innovation are key to breed development, producing premium-quality turkeys of the future. Sustainability: Aviagen Turkeys is committed to developing breeds and adopting internal production practices that not only support cost-effective food production, but also supports social responsibility and environmental sustainability. Aviagen Turkeys is proud to be a leader in both new technologies and environmental stewardship. We will continue to supply the world with a valuable protein source while minimizing environmental impact and emphasizing conservation. Customer Support: Aviagen Turkeys provides support to ensure customers can maximize the genetic potential, efficiency and profitability within their systems. As well as attending many of the global poultry exhibitions to meet customers face to face, Aviagen Turkeys have previously held open days to help guide and support customers within the industry. Aviagen Turkeys provides an exceptional resource of information and expertise to customers, comprising of knowledge and experience gained from productions around the world to maximise the performance of the B.U.T and Nicholas breeds.

BioGX develops molecular products and provides partner-specified formulation and manufacturing services for molecular reagents on a platform of a partner’s choice. The company applies its proprietary platform-agnostic reagent technology to offer products and contract services across a variety of real-time PCR and Next Generation Sequencing platforms.BioGX SARS-CoV-2 Reagents for the BD MAX System - EUA 4/2020

CFD Research Corporation (CFDRC) specializes in engineering simulations and innovative designs for Aerospace, Biomedical, Defense, Materials, Energy, and other industries. Using our software and experimental facilities, we develop new hardware concepts, innovative designs, and prototypes. We have over 50 patents awarded or pending in the areas of biotechnology, combustion, propulsion, and materials. CFDRC’s software and expertise allow coupled multiscale, multiphysics simulations of fluid, thermal, chemical, biological, electrical, and mechanical phenomena for real-world applications. Such simulations provide dearer insights into complex systems and thus enable better decisions and facility better products with lower risk, reduced cost, and less time.

Curiteva is a privately held technology and manufacturing company dedicated to advancing spine surgery and improving clinical outcomes by partnering with providers and suppliers to deliver innovative and intuitive implant systems to the market. Our business is founded on a commitment to building world-class manufacturing, accelerating research and development, maintaining lean operational discipline, and delivering novel technology to meet the evolving needs of our customers and the patients they serve.

A unique laboratory providing accurate and actionable results in one day for infectious diseases and antibiotic resistance genes utilizing innovative molecular technologies, including proprietary TEM-PCR™. Eurofins Diatherix distinctions: - Delivers one-day results - Identifies bacteria regardless of recent antibiotic use - Offers simplicity of single-sample collection - Identifies difficult-to-culture pathogens - Yields a high level of sensitivity and specificity

In many medical settings, devices are commonly used to help doctors treat patients. For example, stents are often used to open blocked arteries, repair torn vessels, and even to keep nasal passages from swelling shut after surgery. Unfortunately these devices fail often resulting in additional surgeries and often replacements of the original device. Endomimetics has developed a BioNanomatrix that can be used to coat these devices and mimic human tissue which minimizes the need for additional surgeries, improves the longevity of the device, reduces complications associated with having foreign items implanted in your body. Applications Our endothelium mimicking nitric oxide releasing BioNanomatrix, initially developed for coronary and peripheral stents, is being assessed for several novel applications including: Stents to help with heart disease Stents and blood flow diverters to help with brain aneurysms Fistula implantation for dialysis patients Intranasal implants for chronic sinusitis sufferers

HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha's vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation's second largest research park. The state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education and fosters more than 45 diverse biotech companies on campus.

Rapid Syndromic Testing for All Labs The mission of iCubate® is to provide rapid, accurate and affordable syndromic testing to all laboratories to ensure care providers have the right tools to improve care and outcomes for their patients. The iCubate® team has developed the iC System™, a low-cost, fully automated, molecular diagnostic platform using armPCR technology, along with a suite of syndromic infectious diseases panels, including sepsis/positive blood cultures, upper / lower respiratory tract infections, GI, mycobacteria, and more. Why iCubate for your lab? • Rapid syndromic testing for infectious diseases for better care, sooner • Affordable system increasing accessibility for large and small labs • Multiplex assay with high target specificity and sensitivity for actionable results • 3 minutes of hands-on time with routine lab processes Twitter: @iCubate FDA Cleared Products iC-System™ (iCubate’s platform) iC-GPC Assay™ for Gram positive cocci Anticipated clearance 2019 iC-GN Assay™ for Gram negative rods Robust Assay Pipeline GI, Respiratory, Mycobacterium

iRepertoire was the first to develop and commercialize immune repertoire sequencing technology and products. iRepertoire uses immune repertoire sequencing technology to access the body’s immunological memory, or “logbook” of all past infection and disease. Sequencing the immune repertoire can yield insights into the nature of the body’s immune response to disease and infection. The future market for iRepertoire will be in clinical and research applications that require immune assessment such as drug treatment monitoring, identification of minimal residual disease (MRD), immune monitoring after stem cell transplantation, vaccine studies, and biomarker development.  iRepertoire provides primer kits and amplification to sequencing services to examine the TCR and BCR immune diversity in both humans and mice. iRepertoire also offers access to its proprietary repertoire analysis tools with the purchase of its regent systems.  iRepertoire’s reagent systems allow researchers to easily and inexpensively generate their own Next Generation Sequencing libraries in the convenience of their laboratory and analyze their data with the iRepertoire’s proprietary software pipeline at no additional cost.This year, iRepertoire has launched automated immune repertoire amplification and extraction on their sister company’s iC-processor (iCubate, Inc.). iRepertoire is proud to be a part of the non-profit initiative R10K, or Repertoire 10,000, with the HudsonAlpha Institute for Biotechnology, which aims to study the immune repertoire of 100 different diseases. The company has developed two key indices to describe the immune repertoire, i.e., the diversity index and the sharing index. These indices allow iRepertoire to identify disease specific signatures for diagnosis, prognosis, and treatment guidance.

iXpressGenes is a synthetic biology company thatspecializes in protein services and instrumentation, and protein and genetic engineering research. The company has experience withextremozymes, microgravity, and trace fluorescent labeling andaccess to a suite of hyperthermophilic genomes from the deep sea vents of the Atlantic Ridge. Proteins and enzymes from these genomes have special qualities that are useful in engineering and metabolic reactions.

Kailos Genetics provides consumers access to affordable physician-ordered genetic tests. It is our mission to help people take control of their health and make more informed decisions. The Kailos test is an easily accessible genetic test catered to your lifestyle.

Microarrays is a biotechnology company that offers array products for biological research, detection, and diagnostics, focusing on advancing array-based technologies.

NuTech Spine was incorporated in 1994 by Founder and President, Ken Horton. Since then, NuTech has been on the cutting edge of Orthopedic, Spinal, and Sports Medicine. NuTech Spine offers quality products & services to its patients and physicians with knowledgeable staff and product literature.

science backed probiotics, prebiotics & bioactive botanicals for targeted restoration res makes physician developed & physician recommended supplements creator of the world's first respiratory probiotic resB!

Welcome and thank you for visiting the Rheumatology Associates of North Alabama. Our dedicated physicians, professional and friendly managers and staff mak

Founded in 1982 to provide researchers with tools that were not readily available from other commercial sources, SouthernBiotech has remained a steadfast, high-quality source of secondary antibodies for research use. Over the years we have expanded our product line to meet researchers’ changing needs. What has not changed is our commitment to customer success.

Southern Research is a nonprofit, translational scientific research organization with an 80-year legacy of moving science through drug discovery, drug development and environmental health. This legacy includes helping shape modern cancer treatment practices by developing seven FDA-approved cancer drugs and co-creating a COVID-19 vaccine currently in clinical trials. These innovations are made possible because of our greatest assets, our people that move science every day at every level of Southern Research.

TriAltus Bioscience is a biotechnology company located in Birmingham, Alabama, that specializes in protein purification and the production of genomic enzymes for the life sciences industry. Founded in 2017, the company utilizes its proprietary CLīM technology to provide high-quality protein products, emphasizing high purity, yield, and activity. The company offers advanced protein purification solutions and produces a variety of genomic enzymes, including CRISPR enzymes, which are known for their quality and affordability. TriAltus Bioscience serves as a reliable protein supplier for innovative biotech and diagnostic companies, contributing to essential workflows in these fields. With a commitment to excellence, TriAltus Bioscience has established itself as a trusted partner in the biotechnology sector.